Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.53 USD | +0.59% | -2.51% | +1.30% |
12:33pm | Wedbush Adjusts Voyager Therapeutics' PT to $8 From $10, Keeps Neutral Rating | MT |
May. 13 | Transcript : Voyager Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
VOYAGER THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +0.65% | -2.51% | +1.30% | -17.79% | -64.05% | 461M |
- Stock Market
- Equities
- VYGR Stock
- Charts Voyager Therapeutics, Inc.
- Relative Strength Chart